133 related articles for article (PubMed ID: 33107558)
1. Laboratory Biomarkers in the Management of Patients With COVID-19.
Weidmann MD; Ofori K; Rai AJ
Am J Clin Pathol; 2021 Feb; 155(3):333-342. PubMed ID: 33107558
[TBL] [Abstract][Full Text] [Related]
2. A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury.
Westerouen van Meeteren MJ; Van den Heuvel FM; Weijers G; Joosten LA; De Mast Q; Van de Veerdonk FL; Pickkers P; De Nooijer AH; Hoefsloot W; Drenth JP; De Korte CL; Nijveldt R; Netea MG; Tjwa ET
J Gastrointestin Liver Dis; 2021 Mar; 30(1):166-168. PubMed ID: 33723544
[No Abstract] [Full Text] [Related]
3. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).
Ciaccio M; Agnello L
Diagnosis (Berl); 2020 Nov; 7(4):365-372. PubMed ID: 32589600
[TBL] [Abstract][Full Text] [Related]
4. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
6. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
Savla SR; Prabhavalkar KS; Bhatt LK
Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
8. Preliminary predictive criteria for COVID-19 cytokine storm.
Caricchio R; Gallucci M; Dass C; Zhang X; Gallucci S; Fleece D; Bromberg M; Criner GJ;
Ann Rheum Dis; 2021 Jan; 80(1):88-95. PubMed ID: 32978237
[TBL] [Abstract][Full Text] [Related]
9. Cardiac biomarkers alterations in patients with SARS-CoV-2 infection.
Oikonomou E; Paraskevas T; Velissaris D
Rom J Intern Med; 2022 Mar; 60(1):6-13. PubMed ID: 34610232
[TBL] [Abstract][Full Text] [Related]
10. Personalized stewardship and interdisciplinarity: key elements of COVID-19.
Lupia T; Corcione S; De Rosa FG
Microbes Infect; 2021; 23(2-3):104781. PubMed ID: 33540071
[No Abstract] [Full Text] [Related]
11. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
12. Coagulation Dysfunction.
Fei Y; Tang N; Liu H; Cao W
Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
[TBL] [Abstract][Full Text] [Related]
14. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
15. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
Pamukçu B
Anatol J Cardiol; 2020 Oct; 24(4):224-234. PubMed ID: 33001051
[TBL] [Abstract][Full Text] [Related]
17. Ischaemic stroke as an initial presentation in patients with COVID-19: evaluation of a case series in an emergency in Brazil.
Oliveira IB; Pessoa MS; Lima CF; Holanda JL; Coimbra PPA
Neuroradiol J; 2021 Aug; 34(4):308-312. PubMed ID: 33455541
[TBL] [Abstract][Full Text] [Related]
18. Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
Pawlowski C; Wagner T; Puranik A; Murugadoss K; Loscalzo L; Venkatakrishnan AJ; Pruthi RK; Houghton DE; O'Horo JC; Morice WG; Williams AW; Gores GJ; Halamka J; Badley AD; Barnathan ES; Makimura H; Khan N; Soundararajan V
Elife; 2020 Aug; 9():. PubMed ID: 32804081
[TBL] [Abstract][Full Text] [Related]
19. What Is a Cytokine Storm and Should It Matter to Me?
Simkin J; Strange T; Leblanc N; Rivera JC
J Am Acad Orthop Surg; 2021 Apr; 29(7):297-299. PubMed ID: 33443384
[TBL] [Abstract][Full Text] [Related]
20. The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
Shi C; Wang C; Wang H; Yang C; Cai F; Zeng F; Cheng F; Liu Y; Zhou T; Deng B; Vlodavsky I; Li JP; Zhang Y
Clin Transl Sci; 2020 Nov; 13(6):1087-1095. PubMed ID: 32881340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
